Literature DB >> 28663678

A Dynamic Definition of Acute Kidney Injury Does not Improve Prognosis Assessment in Acutely Decompensated Patients with Cirrhosis.

Sebastián Marciano1,2, Ezequiel Mauro1, Melisa Dirchwolf1, María Emilia Debernardi3, Diego Giunta2, Vanina Pagotto2, Liliana Rojas2, Adrián Gadano1,2.   

Abstract

BACKGROUND/
OBJECTIVES: to compare the prognostic accuracy for 28 and 90-day transplant-free mortality of a modified CLIF-SOFA score (including a dynamic definition of acute kidney injury) with that of the classic CLIF-SOFA score and KDIGO score for acute kidney injury in patients with acute decompensation of cirrhosis.
METHODS: A retrospective analysis of all admissions of acutely decompensated patients with cirrhosis was carried out from January 2012 to December 2014. Classic and modified CLIF-SOFA scores were analyzed, as well as acute kidney injury diagnosis using the KDIGO score regarding their accuracy for 28- and 90-day transplant free mortality prediction.
RESULTS: 108 admissions were analyzed. Acute kidney injury diagnosis was met in 37 (34%) patients. Acute-on-chronic liver failure was diagnosed in 59 (55%) patients using the classic CLIF-SOFA score; and in 64 (59%) patients using the modified CLIF-SOFA score. Both CLIF-SOFA scores were highly effective in predicting 28-day transplant-free mortality (AUCROC 0.93 and 0.92, p = 0.34) as well as 90-day transplant-free mortality (AUCROC 0.79 and 0.78, p = 0.78). Acute kidney injury diagnosis had significantly lower accuracy in mortality assessment (28 and 90-day transplant free mortality AUCROC 0.67 [p = 0.002] and 0.63 [p = 0.02]).
CONCLUSIONS: To our knowledge, this is the first evidence of the limited impact of modifying the fixed kidney injury definition currently used for acute-on-chronic liver failure.

Entities:  

Keywords:  AUCROC, area under the curve of the receiving operating characteristic; CLIF-SOFA, Chronic Liver Failure-Sequential Organ Failure Assessment; HIV, human immunodeficiency virus; INR, international normalized radio; KDIGO, Kidney Disease Improving Global Outcome; MELD, model for end stage liver disease; acute kidney injury; acute-on-chronic liver failure; mortality; prognostic accuracy

Year:  2017        PMID: 28663678      PMCID: PMC5478969          DOI: 10.1016/j.jceh.2017.03.004

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  16 in total

1.  Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.

Authors:  Paolo Angeli; Pere Ginès; Florence Wong; Mauro Bernardi; Thomas D Boyer; Alexander Gerbes; Richard Moreau; Rajiv Jalan; Shiv K Sarin; Salvatore Piano; Kevin Moore; Samuel S Lee; Francois Durand; Francesco Salerno; Paolo Caraceni; W Ray Kim; Vicente Arroyo; Guadalupe Garcia-Tsao
Journal:  J Hepatol       Date:  2015-01-28       Impact factor: 25.083

2.  Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.

Authors:  Paolo Angeli; Ezequiel Rodríguez; Salvatore Piano; Xavier Ariza; Filippo Morando; Elsa Solà; Antonietta Romano; Elisabet García; Marco Pavesi; Alessandro Risso; Alexander Gerbes; Chris Willars; Mauro Bernardi; Vicente Arroyo; Pere Ginès
Journal:  Gut       Date:  2014-10-13       Impact factor: 23.059

Review 3.  Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis.

Authors:  Vicente Arroyo; Richard Moreau; Rajiv Jalan; Pere Ginès
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

4.  Association of AKI with mortality and complications in hospitalized patients with cirrhosis.

Authors:  Justin M Belcher; Guadalupe Garcia-Tsao; Arun J Sanyal; Harjit Bhogal; Joseph K Lim; Naheed Ansari; Steven G Coca; Chirag R Parikh
Journal:  Hepatology       Date:  2012-12-06       Impact factor: 17.425

Review 5.  Acute-on chronic liver failure.

Authors:  Rajiv Jalan; Pere Gines; Jody C Olson; Rajeshwar P Mookerjee; Richard Moreau; Guadalupe Garcia-Tsao; Vicente Arroyo; Patrick S Kamath
Journal:  J Hepatol       Date:  2012-06-28       Impact factor: 25.083

6.  Acute-on-chronic liver failure: a new clinical entity.

Authors:  Richard Moreau; Vicente Arroyo
Journal:  Clin Gastroenterol Hepatol       Date:  2014-02-28       Impact factor: 11.382

7.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

8.  A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis.

Authors:  Claudia Fagundes; Rogelio Barreto; Mónica Guevara; Elisabet Garcia; Elsa Solà; Ezequiel Rodríguez; Isabel Graupera; Xavier Ariza; Gustavo Pereira; Ignacio Alfaro; Andrés Cárdenas; Javier Fernández; Esteban Poch; Pere Ginès
Journal:  J Hepatol       Date:  2013-05-10       Impact factor: 25.083

9.  Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.

Authors:  Rajiv Jalan; Faouzi Saliba; Marco Pavesi; Alex Amoros; Richard Moreau; Pere Ginès; Eric Levesque; Francois Durand; Paolo Angeli; Paolo Caraceni; Corinna Hopf; Carlo Alessandria; Ezequiel Rodriguez; Pablo Solis-Muñoz; Wim Laleman; Jonel Trebicka; Stefan Zeuzem; Thierry Gustot; Rajeshwar Mookerjee; Laure Elkrief; German Soriano; Joan Cordoba; Filippo Morando; Alexander Gerbes; Banwari Agarwal; Didier Samuel; Mauro Bernardi; Vicente Arroyo
Journal:  J Hepatol       Date:  2014-06-17       Impact factor: 25.083

Review 10.  Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).

Authors:  John A Kellum; Norbert Lameire
Journal:  Crit Care       Date:  2013-02-04       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.